{"abstract": "The approval of a Vertex Pharmaceuticals drug sets off a marketing battle with Merck.", "web_url": "https://www.nytimes.com/2011/05/24/business/24drug.html", "snippet": "The approval of a Vertex Pharmaceuticals drug sets off a marketing battle with Merck.", "lead_paragraph": "Vertex Pharmaceuticals won regulatory approval on Monday for a new hepatitis C drug, setting off a marketing battle with Merck over new drugs that are expected to improve the cure rate of the disease and shorten the duration of treatment. ", "print_section": "B", "print_page": "2", "source": "The New York Times", "multimedia": [], "headline": {"main": "Second Drug Wins Approval For Treatment of Hepatitis C", "kicker": null, "content_kicker": null, "print_headline": "Second Drug Wins Approval For Treatment of Hepatitis C", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "Vertex Pharmaceuticals Incorporated", "rank": 1, "major": "N"}, {"name": "organizations", "value": "Merck & Company Inc", "rank": 2, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 3, "major": "N"}, {"name": "subject", "value": "Hepatitis", "rank": 4, "major": "N"}], "pub_date": "2011-05-23T15:37:06+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Andrew Pollack", "person": [{"firstname": "Andrew", "middlename": null, "lastname": "Pollack", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/c86f670b-6c71-544e-a523-f34b7117bb55", "word_count": 736, "uri": "nyt://article/c86f670b-6c71-544e-a523-f34b7117bb55"}